3/22
02:32 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
3/22
01:48 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/20
08:08 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $220.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $220.00 price target on the stock.
3/20
06:37 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/20
06:37 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/15
09:36 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/1
11:50 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/1
06:24 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
3/1
06:24 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
01:31 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
2/29
01:11 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
12:33 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
2/29
12:33 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $195.00 price target on the stock.
2/29
12:00 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
12:00 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
11:36 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
2/29
07:38 am
jazz
Rating for JAZZ
Medium
Report
Rating for JAZZ
2/29
07:38 am
jazz
Rating for JAZZ
Medium
Report
Rating for JAZZ
1/29
01:09 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
1/29
01:09 pm
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
1/3
08:08 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $160.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $160.00 price target on the stock.
1/3
05:12 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
1/3
05:12 am
jazz
Rating for JAZZ
Low
Report
Rating for JAZZ
1/2
04:26 pm
jazz
Jazz Pharmaceuticals initiated with bullish view at Baird
Low
Report
Jazz Pharmaceuticals initiated with bullish view at Baird
1/2
04:26 pm
jazz
Jazz Pharmaceuticals initiated with bullish view at Baird
Low
Report
Jazz Pharmaceuticals initiated with bullish view at Baird